Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 6,602	$ (5,137)	$ 2,616	$ (9,502)
Available for sale securities - net unrealized (loss) income	(9)	17	(9)	31
Total other comprehensive (loss) income	(9)	17	(9)	31
Comprehensive income (loss)	6,593	(5,120)	2,607	(9,471)
Comprehensive income attributable to noncontrolling interests	4	3	8	5
Comprehensive income (loss) attributable to Caladrius Biosciences, Inc. common stockholders	$ 6,589	$ (5,123)	$ 2,599	$ (9,476)